Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$58.60T
24h Vol:
$4.13B
Dominance:
MSFT:5.14%
Stocklytics Platform
BETA
Instrument logo  MCK

McKesson Corp

MCK
67 / 100
S&P500
$518.00arrow_drop_down-0.23%-$1.20

Performance History

Stocklytics logo
Key Stats
Open$512.46
Prev. Close$510.29
EPS22.1
Dividend$2.32
Next Earnings DateJul 1, 2024
Dividend Yield %0.48%
Market Cap$67.83B
PE Ratio23.36
LOWHIGH
Day Range509.37
516.96
52 Week Range331.75
519.75
Ratios
P/B Ratio5.04
Revenue$276.71B
Operating M. %0.80%
Earnings$3.72B
Earnings Growth %189.20%
EBITDA Margin %1.55%
ROE %0.00%
EPS22.1

Score Breakdown

67vs 53. Market Avg.

All Score 67 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

MCKMARKET
Value2339
Quality6640
Ownership3719
Growth7046
Dividends3337
check_circle

McKesson Corp's Price growth average in the last 3 years of 45.57% is great compared to market average of 6.79%. This indicates MCK could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$769.53
24H (%)arrow_drop_down-0.01%
24H ($)-$0.10
MARKET CAP$731.18B
PRICE$527.23
24H (%)arrow_drop_up0.14%
24H ($)$0.73
MARKET CAP$487.65B
PRICE$161.84
24H (%)arrow_drop_up0.86%
24H ($)$1.39
MARKET CAP$389.83B
PRICE$129.45
24H (%)arrow_drop_up0.14%
24H ($)$0.19
MARKET CAP$328.02B

About McKesson Corp (MCK)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Sector
Healthcare
Industry
Medical Distribution
CEO
Mr. Brian S. Tyler Ph.D.
Headquarters
Irving
Employees
45000
Exchange
NYSE
add McKesson Corp to watchlist

Keep an eye on McKesson Corp

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
What is McKesson Corp's (MCK) price per share?

The current price per share for McKesson Corp (MCK) is $516.24. The stock has seen a price change of $5.94 recently, indicating a 1.16% change. This reflects the stock's recent market performance and investor sentiment.

question_mark
What is the 52-week high and low for McKesson Corp (MCK)?

For McKesson Corp (MCK), the 52-week high is $519.75, which is 0.68% from the current price. The 52-week low is $331.75, the current price is 55.61% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

question_mark
Is McKesson Corp (MCK) a growth stock?

McKesson Corp (MCK) has shown an average price growth of 44.16% over the past three years. It has received a score of 92 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying McKesson Corp as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

question_mark
What is McKesson Corp (MCK) stock price performance year to date (YTD)?

As of the latest data, McKesson Corp (MCK) has a year-to-date price change of 9.07%. Over the past month, the stock has experienced a price change of 6.44%. Over the last three months, the change has been 11.77%. Looking at a longer horizon, the five-year price change stands at 306.01%.

question_mark
Is McKesson Corp (MCK) a profitable company?

McKesson Corp (MCK) has a net income of $3.72B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 4.47% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0.8% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $276.71B, with a revenue growth rate of 4.83%, providing insight into the company's sales performance and growth. The gross profit is $12.36B. Operating income is noted at $4.38B. Furthermore, the EBITDA is $4.53B.

question_mark
What is the market capitalization of McKesson Corp (MCK)?

McKesson Corp (MCK) has a market capitalization of $67.84B. The average daily trading volume is 715.12K, indicating the stock's liquidity and investor engagement.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.